Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (873)
  2. Journal Article (564)
  3. Review (72)
  4. Research Letter (38)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (17)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1415)
  2. Hematologic Malignancies, Division of (1082)
  3. MSK Grad Students (1018)
  4. Center for Hematologic Malignancies (985)
  5. Master of Science in Clinical and Translational Cancer Research (983)
  6. Survivorship Research (917)

More Groups

People
  1. Sergio Giralt (553)
  2. Miguel-Angel Perales (411)
  3. Michael Scordo (385)
  4. Gunjan Shah (341)
  5. Sean Devlin (333)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (98)
  2. 2024 (251)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (83)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (372)
  3. American Society of Clinical Oncology (158)
  4. Nature Publishing Group (134)
  5. Springer (102)
  6. American Association for Cancer Research (65)

More Publishers

Results (1639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Homologous recombination deficiency in pancreatic cancer: Poly (ADP-ribose) polymerase inhibition, checkpoint inhibition, or a combination of both?
    Correspondence

    Keane, F.; Park, W.; O'Reilly, E. M.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Histology-specific prognostication for radiation-associated soft tissue sarcoma
    Journal Article

    Bartlett, E. K.; Sharma, A.; Seier, K.; Antonescu, C. R.; Agaram, N. P.; Jadeja, B.; Rosenbaum, E.; Chi, P.; Brennan, M. F.; Qin, L. X.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Gut dysbiosis suppresses anti-tumor ILC2S in pancreatic cancer
    Meeting Abstract

    Zebboudj, A.; Amisaki, M.; Guasp, P.; Rojas, L.; Sethna, Z.; Theresa, W.; Chandra, A.; Yu, R.; Odgerel, Z.; Soares, K.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Generalizability of predictive versus prognostic indicators from published transcriptomic associations with tumor response to immune checkpoint inhibition
    Meeting Abstract

    Bortone, D.; Monette, A.; Tschernia, N.; Cogdill, A.; Najjar, Y.; Sweis, R. F.; Valpione, S.; Wennerberg, E.; Bommareddy, P.; Haymaker, C.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in solid tumors with defects in polymerase epsilon
    Meeting Abstract

    Rousseau, B.; Bieche, I.; Pasmant, E.; Hamzaoui, N.; Leulliot, N.; Michon, L.; de Reynies, A.; Foote, M.; Masliah-Planchon, J.; Svrcek, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacokinetic (PK) profile of a novel IKZF1/3 degrader, CFT7455, enables significant potency advantage over other IKZF1/3 degraders in models of multiple myeloma (MM) and the results of the initial treatment cohort from a first-in-human (FIH) phase 1/2 study of CFT7455 in MM
    Meeting Abstract

    Lonial, S.; Richard, S.; Matous, J. V.; Yee, A. J.; Shah, U.; Mehta-Shah, N.; Martin, T.; Muchtar, E.; Ailawadhi, S.; Richardson, P. G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • (R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive tumorigenesis in IDH-mutant cancers
    Meeting Abstract

    Gunn, K. E.; Myllykoski, M.; Cao, J.; Huang, B.; Rouaisnel, B.; Diplas, B.; Levitt, M. M.; Looper, R.; Doench, J. G.; Ligon, K. L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Analysis of homologous recombination deficiency (HRD) scores in osteosarcoma
    Meeting Abstract

    Kinnaman, M. D.; Pena, J.; Levine, M.; Bouvier, N.; Papaemmanuil, E.; Forrest, S.; Janeway, K.; Meyers, P.; Bender, J. G.
    Cancer Research (2022)

    Fulltext@MSK | Save